Connect with us

Featured

Stemtech Corp (OTCMKTS: STEK) Drifts Lower with Promo Behind it & New Shares Hitting the Market

Published

on

Stemtech Corp (OTCMKTS: STEK) continues to fall further recently hitting lows of $0.24 per share now that the massive July/August google adds to a landing page promotion is over. At the top of the promotion in August at $11.50 per share STEK reached a market cap of over $1 billion USD, an astronomically high number considering the Company has minimal assets, $33 million in liabilities and averages a little over $1 million in revenues per quarter. We warned investors STEK would end up where it is now in our article in August starting: STEK is a major league promotion from some heavy hitters that could easily go much higher but when the bottom falls out, it could drop fast.”  

In our last article in September on STEK we reported: “We think STEK could continue to move lower and will eventually trade below $0.25 per share. According to management they have no idea what’s going on stating in a recent press release: “they were notified by OTC Markets of a foreign stock promotion which we were unaware of, and provided Stemtech Corporation with a copy of an article from a UK web site called “World Finance”, which emphatically predicted share price appreciation in the Stem Cell arena in general, and our Company in particular. Earlier this year, before STEK rocketed to $11.50 per share debtholders got a sweetheart deal according to the filing: “by agreement of all then existing debt holders and old management, all pre-existing debts were converted out to 6,000,000 shares, which equates to $0.09 per share. “ 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Stemtech Corp (OTCMKTS: STEK) is a global network marketing company that develops science-based products that it believes supports wellness by helping the body maintain healthy stem cell physiology, also known as stem cell enhancers. Known as the Stem Cell Nutrition Company®, the Company is a pioneer in stem cell science, and believes it can demonstrate that adult stem cells function as the natural renewal system of the body. The Company believes its products enhance and support the work of the body’s stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where they can perform their daily function of renewal for optimal health. The Company’s mission is to enhance wellness and prosperity around the world. These products are marketed internationally by the Companies subsidiaries and through independent distributors. The Company markets its products under the following brands: RCM System, stemrelease3™, Stemflo® MigraStem™, DermaStem®, DermaStem Lift, OraStem® (Oral Health Care), and D-Fuze™. 

Stemtech has pioneered and patented a whole new category of dietary supplements. Stemtech’s advanced Stem Cell Nutrition formulations are one-of-a-kind natural products designed to help support the three most important aspects of stem cell physiology: 1) Releasing more stem cells; 2) their circulation in the blood; and 3) Migration into tissues, where they can perform their daily function of renewal and rejuvenation for optimal health. We actually harness the incredible power of adult stem cells. How does this work? Adult stem cells are released from your bone marrow into the bloodstream, they then Circulate in the bloodstream and flow to the tissues most in need. As they arrive, the adult stem cells migrate into the tissues, reproduce and become new, healthy cells of those tissues. This process takes place every single day, even without tissue damage, as part of the natural renewal system of the body. It is important to understand that Stemtech’s products do not contain stem cells. They are composed of natural botanicals and other ingredients that have been clinically documented to support the performance of your own adult stem cells. 

The Company is now reengaging over 200,000 former distributors since a recent cash infusion. STEK has engaged experienced marketing and social media professionals to initiate new marketing strategies which are expected to bring increased activity. Moreover, it is now better positioned to absorb significant new clientele as the company has directed significant cash towards our inventory, and we now have enough inventory on hand to fulfill over $3 million dollars’ worth of new orders, an inventory level we have not had since going into bankruptcy in 2017. Management conservatively believes that given the cash on hand and working expenditures as describe above, it can reinvigorate sales to be more consistent with the company’s previous revenue historically, as it was recognized 4 times in the Inc 5000 Magazine’s list of fastest growing companies. 

To Find out the inside Scoop on STEK Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

STEK

Earlier this year the Company acquired Life Factor Research, a leading manufacturer in the nutraceutical world. Charles Layton, CEO of Life Factor Research commented that “from our beginnings, Life Factor Research has held fast to our foundational concept of creating nutraceutical products that through their proprietary nature and scientific proof create lasting change for our clients and their customers. During our progress in the highly expanding anti-aging space, we have had a core desire to align ourselves with the right “strategic partner”, and with great pride and anticipation of what is to come we are most grateful to be able to announce our alignment with Stemtech Corporation. Over the last year our team has had the opportunity to get a deep understanding of Stemtech’s core values in the Stem Cell rejuvenation space and at the same time gain an appreciation for the distribution channels that will now be reached as a result of this union. LFR has aggregated tremendous proprietary compounds, formulations, delivery and absorption technologies as well as patents that will be introduced into the market in truly revolutionary products which will, in some cases, be category creating. As the CEO of Life Factor Research, it would be impossible for me to overstate our collective potential in a space that is experiencing growth at a level which has been exploding year over year.” 

On November 7 STEK re-iterated the growing scientific understanding of the significance of stem cells as a key benefit in health. This is validated by the amount of funding in R&D efforts underway as reported by Research and Marketing publication. More businesses are realizing the opportunity for helping people as well as profitability, something Stemtech saw over 17 years ago when they created and opened their commerce in the stem cell nutrition sector. 

Stemtech Corporation President and Chief Operating Officer, John W. Meyer, said “Stemtech strategically focuses on the creation of new and cutting-edge stemceuticals, including skin care, anti-aging, natural well-being and longevity with emphasis on the use of the bodies’ own stem cells to facilitate better health, rejuvenation and overall wellness. Stemtech now has Life Factor Research (LFR) as our R & D division for development of new products for an ever-growing market interested in improved quality of life and better health. Improving internal health and external wellness is our strategic direction. The first new Stemtech skincare product designed by LFR will be unveiled at the December Cancun leadership event, with more to follow in 2023. Stemtech has always known that the field of stem cells would gain momentum, whether via biotech or pharma seen by the expansion of research as reported by Research and Marketing, where investment funding is expected to grow from $1.9 billion in 2022, to an estimated $4.5 billion by 2027.” 

Investment bankers Tully & Holland, opine that “A long-running socioeconomic shift toward increased health consciousness was further accelerated during the pandemic. Consumers realize that there is simply no substitute for good health and are increasingly focused on treating their bodies with greater care and respect. Whether through diet, exercise, or a combination of both, supplement consumption is a core tenant of this perception.” They go on to say “this has opened a market for producers to specialize products at the individual consumer level and created a new wave of innovation.” Stemtech has been focused on this since 2005. Stemtech is listed as one of 25 publicly traded companies in this market space by Tully & Holland. 

Cliff Layton, CEO of Stemtech’s Life Factor Research Division, says “LFR has aggregated tremendous proprietary compounds, formulations, delivery and absorption technologies as well as patents that will be introduced into the market, truly revolutionary products which will, in some cases, be category creating. The collective potential in a space that is experiencing growth at a level never seen before will enable Stemtech to continue to be a leader in the stem cell technology market and much more.” 

 For More on STEK Subscribe Right Now!

Currently trading at a $13 million market valuation, STEK OS is 48,625,346 and the float is around 11 million shares. STEK is an SEC filer and fully reporting OTCQB. The Company has just over $500,000 in the treasury and $5.1 million in assets vs. $30 million in liabilities. STEK was a major league promotion in July/August via google adds to a landing page promoting Stemtech Corp. Now that the promotion is over the stock has continued to move lower recently hitting lows of $0.24 per share. STEK has a major debt problem and this debt continues to be converted into stock by 3rd party’s with the OS increasing by over 4 million shares just in the past 2 months. As new shares continue to flow into the market the price per share will continue to drop lower. We will be updating on STEK when more details emerge so make sure you are subscribed to Microcapdaily.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in STEK either long or short and we have not been compensated for this article.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

Global Tech Industries Inc (OTCMKTS: GTII) Declares War On Shorts

Published

on

Global Tech Industries Inc (OTCMKTS: GTII) has filed a lawsuit against Alpine Securities for spoofing and depressing the share price of GTII.

Global Tech Industries Inc (OTCMKTS: GTII) has filed a lawsuit against Alpine Securities for spoofing. The lawsuit claims that multiple parties were selling a significant number of shares at artificially depressed prices, which is attributed to the illegal behavior of spoofing.

According to David Reichman, CEO of GTII, the lawsuit is a significant step in the company’s efforts to protect itself and its shareholders from market manipulation. The company is represented in the case by the Christian Levine Law Group and Warshaw Burstein, LLP, two law firms that specialize in stock fraud litigation.

To Find out the inside Scoop on GTII, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The spoofing of shares refers to a fraudulent trading practice in which traders place buy or sell orders for a security, intending to cancel them before they are executed. This behavior creates a false impression of demand, causing the market price to move in a specific direction, which benefits the trader’s position. Spoofing is a violation of federal securities laws.

The lawsuit alleges that the financial firms named in the complaint engaged in illegal behavior that allowed them to manipulate the market and benefit from GTII’s artificially depressed share prices. GTII is seeking unspecified damages and injunctive relief to prevent further market manipulation.

Wes Christian, managing partner of the Christian Levine Law Group, stated that the lawsuit is yet another example of illegal market manipulation by the defendants. He emphasized the law firm’s commitment to protecting shareholders and holding financial firms accountable for their illegal behavior.

The lawsuit is an important step for GTII in its ongoing efforts to protect its shareholders and business from illegal market activities. It remains to be seen how the lawsuit will unfold, but GTII is committed to pursuing legal action against those who engage in market manipulation that harms the company and its shareholders.

Alpine Securities is in significant trouble and cannot pay the $2 million fine imposed on them by the SEC. GTII has the highest concentrated short position in Alpine’s books, which is significant. GTII needs to fight against this illegal behavior, and a lawsuit is one of the ways to do so.

Taking a step back and understanding the entire Alpine situation as a whole, it is clear that they are in trouble. The current market conditions, where the fluidity of credit is not as strong, can significantly affect borrower rates. When borrowing rates go through the roof, as was the case with GTII, it does not make sense to short-sell. People had to cover, and the stock went nearly double all-time highs to $9.

GTII has many catalysts, and the first one will be Upstream, which will open multiple avenues to throw a curveball at short sellers with special coupons and dividends. The 1-800 Law Firm deal is another catalyst that GTII is excited about. GTII expects to receive $85 million in receivables on the books, which will improve GTII’s fundamentals exponentially. This improvement in fundamentals could make the current resistance level of $2 the new floor.

Restricted dividends are another way GTII can throw a curveball at short sellers. Clean Vision’s success with restricted dividends is an example that worked in the recent past. The proof is there that it can work and is worth trying. If it is another curveball that can throw off a short seller, that’s perfect. It can’t hurt to try, especially if it is restricted, which means it will not dilute the stock for six to 12 months.

For more on GTII, Subscribe Right Now!

GTII is in an exciting time, where banks are collapsing, and the market is getting rocked. Everyone is very tense, and there is a lot of pressure. Things are not as smooth as they were a year or two ago, so this could be a really good time for GTII. Many things are happening right now, including the 1-800 deal coming in two or three weeks, the Alpine update from the SEC in two to three weeks, the special dividends, and the lawsuit against Alpine.

When looking at the chart, GTII is testing a key level again. The $2 level has been struggling to hold above this range, but it is about to be retested again.

GTII Daily Chart

GTII Daily Chart

In conclusion, GTII has dropped a hammer on Alpine Securities by filing a lawsuit against them for spoofing. GTII is fighting back against illegal behavior and has many catalysts to help them. The current market conditions are not smooth, but GTII is in an excellent position to take advantage of this situation. With the lawsuit, the 1-800 deal, the Alpine update, and the special dividends, GTII is well-positioned to move forward.

MicroCapDaily sees GTII as one of the most exciting stories to follow. We will keep an eye on this one and push out updates as they unfold.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Hilary Clark from Pixabay

Continue Reading

Emerging Markets

Is today’s surge in MMTec Inc (NASDAQ: MTC) justified ?

Published

on

MMTec, Inc. (NASDAQ: MTC) ended the day at $2.0700 with a gain of $0.5800 (+38.93%). The stock prices fluctuated between $1.4000 - $2.5299, with more than 2.98M shares exchanging hands.

MMTec, Inc. (NASDAQ: MTC) ended the day at $2.0700 with a gain of $0.5800 (+38.93%). The stock prices fluctuated between $1.4000 – $2.5299, with more than 2.98M shares exchanging hands.

So why did MTC surge today ?

The failure of Silicon Valley Bank led to a sell-off in equities and a shift to safe-haven assets, such as US Treasuries and gold. Markets have calmed down somewhat, and the worst of the equity sell-off seems to be over. However, the market anticipates that the markets will be somewhat uneasy until a better understanding of inflation is reached and what the Federal Reserve will do next week.

To Find out the inside Scoop on MTC, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Despite most investors currently avoiding the banking sector, Wall Street sees potential opportunities, particularly in regional banks. The chaos in the market has created opportunities in the industry and several banking stocks are being punished just for being a banking stock. The collapse of Silicon Valley Bank was due to its specialisation in venture-capital financing, which made it vulnerable to the higher interest rate regime of the past 12 months.

For more on MTC Subscribe Right Now!

Therfore, today’s gains in MTC seems to be more a sympathy bounce considering the overall banking sector. Earlier in March, MMTEC, Inc. (Nasdaq: MTC) declared that it will relocate its operations from Beijing to the Hong Kong Special Administrative Region, effective March 6, 2023. The Company’s subsidiary, MM Future Technology Limited, which is a Hong Kong incorporated limited company, will assume all operations previously conducted by its subsidiary, Gujia (Beijing) Technology Co., Ltd. However, Gujia will continue to carry out specific technical research and development functions. Further, the Company, through its subsidiary HC Securities (HK) Limited, and other entities, will continue to invest its human resources in asset management and securities underwriting, and other related businesses, aiming to attract global funds to invest in the Chinese market and support China’s economic growth. The Company’s new operations headquarters is located at Room 2302, 23rd Floor, FWD Financial Center, 308 Des Voeux Road Central, Sheung Wan, Hong Kong.

We will be updating on MTC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with MTC.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have no position in MTC and have not been compensated for this article.

Continue Reading

Featured

Global Developments Holdings, Inc (OTCMKTS: GDVM) Share Starts Recovery After a Second Big Drop in Three Months

Published

on

Global Developments Holdings Inc (OTCMKTS: GDVM) share has steadily risen for the past six and a half months. The company’s performance in 2023 has been remarkable.

Global Developments Holdings Inc (OTCMKTS: GDVM) share has been on a steady rise for the past six and a half months. The company’s performance in 2023 shows that the share was growing, then it saw a sudden surge, only to crash back down. However, the company’s 6M chart clearly indicates that the share has been rising steadily, and both rapid surges followed by sudden crashes — one in November/December 2022 and another in February 2023 — were only brief pumps. The stock’s performance overall still indicates that GDVM is seeing a strong, steady rise, which was not affected by these instances of strong volatility.

The GDVM price was fairly stable for the first eight months of 2022, slightly fluctuating around $0.0040. However, at the end of August 2022, the price started to grow. The growth was steady, healthy, and the price kept going up, almost completely uninterrupted until November 3rd. At the time, it reached $0.0527, but after reaching this level, it saw a slight correction to a support at $0.040. After only about a week at this level, a rapid surge took it all the way up to $0.1109. The surge started around November 16th, and it reached its peak by December 6th.

After that, a rapid correction made the price crash back down to $0.056 later on the same day. After an attempt at recovery, the price dropped again on December 14th, this time sinking to $0.038. From there on, the price managed to return back to its steady growth, which actually lasted until late January 2023. At the time, it reached $0.066, when another surge took place, starting on January 27th.

To Find out the inside Scoop on GDVM, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

In the following month, the price climbed up to $0.1359, reaching this height on February 23rd, which was once again followed by a rapid crash back to $0.0726. What followed was a few weeks of stability, which led the price to finally grow back up again, to $0.0862, on March 9th. This was followed by another mild correction to $0.769, which is where the GDVM price sits right now at the time of writing.

Global Developments Holdings, Inc (OTCMKTS GDVM) Share Starts Recovery After a Second Big Drop in Three Months

Global Developments Holdings, Inc (OTCMKTS: GDVM) price behavior has been quite significant over the last six months. However, it is also worth noting that most of these developments — the beginning of the six-month steady growth, as well as rapid price surges in between — took place when some major developments for the company happened. For example, the price started climbing up in August after reports that it reduced OS by 525 million, with rumors that significant moves are being made behind the scenes. At the time, it was rumored that the company was planning a reverse merger, which is exactly what it was doing, as it was discovered later on.

Following that, reports in November emerged, noting that the reverse merger is heating up, especially as the new CEO was affected by massive share reduction. The merger was with a company VeeMost, and by early December 2022, it achieved its 4th advanced specialization. At the time, reports were also praising GDVM as its stock price continued to skyrocket. The stock has been under heavy accumulation from the moment Mr. Melvin Ejiogu, an executive who also acts as President of VeeMost Technologies, became the controlling shareholder. He said:

$GDVM majority control acquired and all outstanding debt purchased. I also purchased 12% of outstanding shares and returned them to the treasury. No dilution will occur. I’ll be sharing updates soon with everyone on our new journey.

His new dilution policy affected a massive share reduction, as mentioned, and trapped the market makers, who were seriously short. The reverse merger stocks have proven that they can be much more explosive than biotechs, assuming that the incoming company has real value. By mid-February, Global Developments became the highest overall rated company in the Shell Companies industry. It had an overall score of 66 while and an average score of 43. This means that, on average, the stock in this industry tends to score higher than 43% of the stock market. However, according to Ejiogu’s tweet published on February 17th, he was working on getting the shell status removed from GDVM.

Global Developments Holdings, Inc (OTCMKTS: GDVM) is a company that provides expert consulting for businesses. It is a principal investment firm that specializes in acquisitions and early-stage financing of emerging growth companies. It describes its service as fast and reliable, and it can help whether its clients need help with finances, advice on theoretical matters, or assistance with practical tasks.

For more on GDVM Subscribe Right Now!

It has a highly-qualified team that is happy to assist with any needs in both private and commercial spheres. The company is based in Delaware, and it was incorporated on December 9th, 2004, as Autobahn International, Inc. However, in 2016, it rebranded to Global Developments Inc and then once more to Global Developments Holdings, Inc, on September 20th, 2018.

For the time being, the company’s stock is still growing steadily after starting to increase in August of last year. The past price surges, followed by sharp corrections, are fairly normal behavior. Prices tend to surge after beneficial developments, and a sharp rise is always followed by a sharp correction. The positive thing is that the price continues to increase after the correction is over, and the chart above clearly shows that the company continues to thrive under the new leadership. We will be updating on GDVM when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with GDVM.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have no position in GDVM and have not been compensated for this article.

Image by David Mark from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.